Diabetes pill tested to stop disease before it starts
NCT ID NCT05426525
Summary
This study is testing if a medication called empagliflozin, already used to treat type 2 diabetes, can help people with prediabetes. Researchers want to see if taking the drug for 13 weeks improves how the body handles blood sugar in 60 overweight or obese adults. The goal is to understand if this approach could help prevent these at-risk individuals from developing full diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oregon State University
Corvallis, Oregon, 97331, United States
Conditions
Explore the condition pages connected to this study.